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In “Trends and racial disparities for acute kidney injury in
premature infants: the US national database,” Dr. Elgendy
and colleagues report that White preterm infants have signif-
icantly less acute kidney injury (AKI) than Black, Hispanic, or
Native American infants [1]. While this is a novel finding,
unfortunately, the increased prevalence of AKI among Black
infants is in line with several recent publications describing
disparities in NICU care and outcomes [2].
Well-described racial health disparities in maternal and neo-
natal health have been documented in the literature for decades.
This phenomenon is disproportionately seen amongBlack births,
where rates of prematurity are 1.5 times higher than non-Black
births [2]. As the authors note, of central concern to the nephrol-
ogist when considering the kidney health implications of preterm
birth is the arrest of nephrogenesis. In addition, other kidney
health risk factors are of concern in the context of prematurity,
including exposure to nephrotoxic medications, hemodynamic
instability, delivery of proper nutrition, and infection. Low birth
weight has also been identified as a risk factor for kidney disease
in these children [3]. The increased rate of prematurity among
Black babies when compared to non-Black babies could help to
explain the AKI disparity described by the authors.
The authors describe a novel disparity in AKI rates among
premature neonates by racial category. Key to understanding this
phenomenon is an appreciation of the close interplay between
social determinants, pathologic risks inherent to prematurity, and
resulting health outcomes. This relationship is important because
it portends an upstream determinant of downstream disparity.
What is more, an unhealthy through-line can be drawn across
the spectrum of pediatric kidney disease: from the neonatal AKI
disparities experienced by babies born prematurely, to kidney
health disparities experienced by children with chronic kidney
disease (CKD), and those who progress to stage 5 CKD. While
there are several important points raised by this manuscript, we
also would like to identify some opportunities for future research
and advocacy.
Importance of terminology and language
Race is a social construct created and maintained by society.
To a large extent by design, the term “race” represents a col-
lection of people organized around a social identity as well as
shared ancestry and phenotypic characteristics. Biological
characteristics found to be different between races are thought
to be due to differing frequencies of gene variants linked to
ancestral geographic regions [4]. Patterns of expression of
these gene variants are altered by physical, psychological,
social, and environmental factors which have been historically
and reductively grouped by skin color. As a social construct,
there exists no biological basis for racial categorization, and as
such, race-based pathologic conclusions are inherently fraught
[5]. Thus, when studying outcomes by race, psychosocial and
socioeconomic factors ideally should be explored when
attempting to define associations with an outcome.
Black or African American people represent over 13% of
the population in the USA. We note that there is nuance in
racial vocabulary, and that the terms African-American and
Black are often used interchangeably both in lay writing and
research. The term African-American refers to those with
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ancestral geographic lineage from the African diaspora and is
rooted in the cultural underpinnings of American slavery. The
term Black is a more inclusive term [4]. For this commentary,
we will use Black, for consistency with the original article and
for these reasons.
While racially disparate health outcomes are well-
demonstrated across all care continua, it is widely accepted
that these differences are not related to race, but instead to
racism and its pervasive effects on life [6, 7]. This includes
neonatal care and outcomes [2]. Racism is defined as a system
of structuring opportunity and assigning value based on the
social interpretation of how one looks (which is what we call
‘race’) that unfairly disadvantages some individuals and com-
munities and unfairly advantages other individuals and com-
munities [8]. As a social determinant of health, racism nega-
tively contributes to neonatal outcomes by exacerbating the
impact of structural adversity and institutionalized deprivation
[9]. When it comes to adverse health outcomes in newborns,
racism always makes health outcomes worse.
Disparities in the neonatal ICU and neonatal
outcomes
Before talking about racial disparities in NICU outcomes,
racial disparities in pregnancy and preterm birth rates
need to be addressed. Black women are three times more
likely than White women to die from pregnancy-related
causes, Black babies are more than twice as likely as
White babies to die before 1 year of age, and non-White
women are up to 1.5 times more likely to give birth pre-
maturely [10]. Despite increased attention to these issues,
disparities in preterm birth rates have worsened over the
past decade [10]. This is a complex issue with contribu-
tions from maternal health, management of pre-existing
conditions, and social determinants of health, such as
health care coverage, poverty, and access to prenatal care.
In this article, Elgendy and colleagues hypothesize that
the increased rates of AKI in premature Black infants
may be secondary to utilization of prenatal care. While
this is one possibility, this disparity may also be related
to lack of access to prenatal care or equitable care com-
pared to non-Black mothers. Further research and care-
ful analysis are needed to determine how other racial
factors affecting pre-pregnancy care, pregnancy care,
and preterm birth rates may be playing a role in the
disproportionate AKI prevalence in the NICU.
Furthermore, Black, Hispanic, and Asian infants are
segregated among NICUs and are treated in units with
lower quality scores [11]. While racial and ethnic dispar-
ities have improved in extremely preterm infants over the
last two decades, significant gaps remain [12]. For exam-
ple, Black women have twice the risk of having a low
birth weight infant than non-Black women [13].
Similarly, the risk of preterm birth and higher mortality
still exist among Black women when evaluating trends
over the past five decades [14]. In order to identify and
begin to address these disparities in the NICU, Horbar and
colleagues have delineated specific actions that can be
taken and are organized into six discrete categories [15].
In Table 1, we have used these categories and applied
them specifically to the diagnosis of AKI in the NICU.
Importance of AKI Identification in the NICU
In their article, Dr. Elgendy and colleagues report a preva-
lence of AKI of 1.5% in prematurely born infants. We note
that this prevalence is from the National Inpatient Sample
(NIS) and is solely based on ICD-9 and ICD-10 coding. This
rate of recognized AKI is dramatically lower than studies of
similar patient populations which determined AKI based on
serum creatinine change or urine output decreases [16].
Previous studies, such as Assessment of Worldwide Acute
Kidney Injury Epidemiology in Neonates (AWAKEN),
found rates of close to 40% among high-risk infants born
< 28 weeks [16]. The low AKI prevalence in this article is
similar to other studies which have shown that AKI is un-
derappreciated by neonatologists, and studies which rely on
documentation in the medical record likely under-report
AKI [17, 18].
This article is the first to report racial disparities in AKI
among infants, finding that Black infants had a higher
prevalence of AKI diagnosis than White infants.
Multiple studies have demonstrated that Black infants
are more likely to be small for gestational age or have
intrauterine growth restriction than their White peers
[12]. Due to this, it is challenging to unequivocally state
which is the underlying, or causal, risk factor. We note
that the AWAKEN study did not report a statistically sig-
nificant difference in AKI prevalence between Black and
White infants [19]. However, the findings of this article
are similar to database-based reporting of AKI in pediatric
patients, where Black pediatric patients had a greater rep-
resentation of AKI hospitalizations [20]. Further research
and analysis, especially that utilize causal inference meth-
odology to determine the independent effect of factors that
are components of larger complex systems, are urgently
needed to address these issues [21].
It is also important to note that disparities in AKI are not
the same as disparities in AKI reporting. Low rates of AKI
reporting in infants are multifactorial in nature, as there are
multiple steps between an infant having AKI and a neona-
tologist making a diagnosis of AKI in the medical record.
First, an infant has to be recognized as high risk for AKI.
Large studies have used various criteria to stratify risk of
AKI. For example, the AWAKEN study considered infants
receiving intravenous fluids for at least 48 h to be high risk
[22]. Others have advocated expanding these criteria to
those needing invasive respiratory support, more than 48 h
of intravenous antibiotics, or at times of events (such as
necrotizing enterocolitis or patent ductus arteriosus treat-
ment with indomethacin) which may increase the risk of
AKI. Secondly, serum creatinine and urine output must be
closely monitored in order to detect changes in kidney func-
tion. There is significant variation in frequency and intensi-
ty of serum creatinine and urine output monitoring between
NICUs based on differences in clinical practice [23]. There
is not yet a standardized approach to serum creatinine or
urine output assessments, which further complicate the di-
agnosis of AKI. Finally, even if AKI is detected by serum
creatinine or urine output change, these changes must be
noted by the care team and recorded in the medical record
in order to be provider recognized. Studies have found that
only 10–30% of infants with AKI are diagnosed by their
care team [17, 18]. We note with significant concern that
there are multiple opportunities throughout these steps that are
inherently at risk of implicit bias, for example the frequency of
serum creatininemeasurement. Each of these is an opportunity to
improve equitable provision of care (Table 1).
Disparities in AKI to CKD
The disparities in neonatal AKI reported by Elgendy and
colleagues are important because they not only have sig-
nificant early life implications but also consequences
along the life course. Pediatric AKI has also been shown
to occur more frequently in Black children and adults,
though this is one of the first studies to demonstrate this
disparity in neonates with AKI [24, 25]. Genetic risk var-
iants of the apolipoprotein L1 (APOL1) gene are often
cited as an explanation for the disproportionate frequency
of AKI among Black persons; however, this association is
not consistent in AKI literature. In a large adult study
demonstrating a disproportionate incidence of AKI among
Black persons, accounting for income and insurance sta-
tus attenuated the risk of AKI among Black persons [24].
There was no association between the presence of high-
risk APOL1 gene variants and AKI among Black adults.
Given that the majority of individuals who carry the high-
risk APOL1 genotype do not have kidney disease, greater
exploration of socioeconomic factors and racial biases in
pediatric AKI is warranted. For the neonatal population,
this may also suggest a larger influence of maternal in
utero factors rather than genetics.
Table 1 Suggestions for Improved NICU practices for Infants with AKI
General NICU AKI specific
Promote a culture of equity - Provide AKI education that reaches all NICU parents regardless
of race
- Develop AKI education for providers that is independent of
race-related risk factors
- Acknowledge implicit personal bias when caring for infants in
the NICU
- Create an AKI NICU disparities dashboard
Identify social risks of families and provide
interventions to prevent and mitigate those risks
- Create alliances with community organizations to teach about
AKI, preterm risks
Take action to assist families after discharge (transition home) - Tailor education on long-term AKI outcomes to each family’s
needs
- Improve communication with families about AKI and CKD risk
- Provide ongoing nephrology follow-up for infants with AKI to
improve early identification of CKD
- Partner with primary care providers to provide care for infants
with AKI to decrease barriers to follow-up care
Maintain support for families through infancy - Ensure nutritional and medication programs are available for
those with a history of AKI
- Improve communication of AKI diagnosis to providers in order
to optimize appropriate CKD surveillance
Develop robust QI efforts to ensure equitable, high-quality hospital and
follow-through care to all newborns by eliminating modifiable disparities
- Establish measurable improvement aims related to social
determinants of neonatal AKI
Advocate for social justice at the local, state and national levels - Disseminate research on disparities in AKI diagnosis
- Educate organizational leaders on social determinates of AKI
- Name racism: how is racism affecting neonatal AKI diagnosis?
AKI acute kidney injury, CKD chronic kidney disease, NICU neonatal intensive care unit, QI quality improvement
AKI has also been shown to lead to irreversible kidney
injury and decreased kidney function. This is thought to pre-
dispose to additional episodes of both AKI and CKD that may
manifest in late childhood or adulthood. Research has shown
that up to 50–60% of children with AKI experience the long-
term sequelae of CKD [26, 27]. The pathophysiology under-
lying AKI to CKD progression is multifactorial and thought to
be dependent upon patient background including severity, du-
ration, and prior frequency of AKI events [28]. These changes
may be more notable in prematurely born infants due to de-
creased nephron number (oligonephronia) and reduction in
future development of nephrons due to premature birth [29].
These factors make early life exposure toAKI especially prob-
lematic for life course and the development of CKD. The
identification of AKI among infants is essential in order to
allow for appropriate monitoring for CKD. In addition, there
is a propensity for more rapid progression to stage 5 CKD in
Black children and adults. Unlike studies of AKI in Black
Americans, many adult and pediatric studies have shown an
association between APOL1 gene variants and CKD.
Nevertheless, only 13% of the US Black population carries
the APOL1 high-risk genotype, highlighting the importance of
additional research beyond race and the APOL1 genetic vari-
ant in kidney disease.
Given the increased risk of CKD in those born prematurely,
appropriate identification and communication of a diagnosis of
AKI is essential to improve ongoing outpatient management and
care for infants. Theoretical models show how interactions be-
tween social determinants of health (i.e., psychosocial and envi-
ronmental factors), racial biases, and the presence of the APOL1
genotype in individuals of African descent may contribute to the
heightened CKD risk [30]. Knowing these factors and under-
standing how they contribute to the risk of AKI is critical to
instituting healthcare policies and guidelines to reduce AKI and
ultimately CKD disparities. Future research is needed to assess
social determinants of health and other factors beyond race and
the association with AKI.
Disparities in pediatric stage 5 CKD
As children with neonatal AKI age, they are at in-
creased risk of progressive CKD including stage 5
CKD, where they face additional racial health disparities
that impact outcomes. In addition to facing troubling
neonatal disparities, Black children experience a time
to dialysis initiation that is 38% shorter, but a time to
transplant that is 54% longer than their non-Black coun-
terparts [3]. Post-transplant, these disparities persist:
Black children are 50% more likely to have kidney
allograft failure and are more likely to experience acute
allograft rejection [3]. In fact, allograft failure rates for
Black children are higher than non-Black children after
controlling for co-variates like socioeconomic and pri-
vate versus public insurance status [31]. Disrupting this
chain may require nephrologists to intervene beyond
biological determinants of health and begin to address
the social determinants of health as well.
The quest to eliminate racial disparities in neonatal AKI out-
comes is unlikely to result in the identification of some elusive
allelic variation that predisposes Black babies to this adversity.
Instead, it will likely require an “all hands-on deck” approach to
decreasing the incidence of preterm birth, and mitigating the
harm of structural racism and other social determinants of health
on neonates both inside and outside of the NICU [32].
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